Skip to content
Screener

DBV Technologies DBVT Accounts Payable

Accounts Payable at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$3.35M+41.5%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$3.73M+51.4%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$11.89M-3.2%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$14.68M+608%
Alumis Inc. logo
Alumis Inc.ALMS
$11.59M+55.1%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$10.03M-43.8%

Other financials

Income statement

See full
Revenue$700.0K-53.3%
Operating income-$50.6M-23.1%
Net income-$50.4M-20.3%
EPS (diluted)-$0.12+61.3%

Balance sheet

See full
Cash & equivalents$174.9M+69.5%
Total debt$7.7M+0.1%
Total equity$160.4M+86.1%
Total assets$223.2M+55.6%

Cash flow

See full
Operating cash flow-$52.6M-55.2%
CapEx$400.0K
Free cash flow-$53.0M-56.3%

Valuation

See full
Market cap$847.16M+218%
Enterprise value$679.96M+297%
P/S168.8×+100×

Profitability

See full
Operating margin-3,543.1%+523pp
Net margin-3,506.5%+442pp
FCF margin-3,399.3%+3,268pp

Returns & leverage

See full
Return on equity-142.7%-5.0pp
Debt / equity0.0×
Current ratio3.7×+1.3×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.

The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.

Filed
Jul 16, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-048453
Line itemNoteJune 30, 2026December 31, 2025
Total Assets223.2233.7
Liabilities and shareholders' equity
Current liabilities:
Trade payables739.440.9
Short-term operating leases' liabilities60.81.1
Current contingencies & Employee Benefits110.40.2
Other current liabilities713.815.8
Total current liabilities54.358.0

Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of

FAQ

What is DBV Technologies's accounts payable?
DBV Technologies (DBVT) reported accounts payable of $39.4M in Q2 2026.
How has DBV Technologies's accounts payable changed year-over-year?
DBV Technologies's accounts payable decreased by 3.4% year-over-year, from $40.79M to $39.4M.
What is the long-term trend for DBV Technologies's accounts payable?
Over 5 years (2020 to 2025), DBV Technologies's accounts payable has grown at a 15.0% compound annual growth rate (CAGR), from $20.34M to $40.9M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.

Ask your AI about DBV Technologies's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude